Literature DB >> 7131636

Diazepam as an anti-motion sickness drug.

J A McClure, P Lycett, J C Baskerville.   

Abstract

Diazepam has been used empirically for the relief of vertigo and, in addition, there are animal studies to suggest that this drug suppresses the vestibular system. One might anticipate therefore that diazepam would be an effective antimotion sickness drug. To study this, motion sickness was generated in four groups of normal subjects by having the subject make controlled head movements while rotating at constant velocity. Every subject was subjected (using a double-blind technique) to four different drug states, namely no drug, placebo, dimenhydrinate, and diazepam. Each group of subjects received the drug state at a different time interval (i.e. 30, 60, 90, and 120 min) prior to the motion sickness exposure. Motion sickness endpoints were measured subjectively using a nausea scale and objectively using a sweat sensor. The results showed significant antimotion sickness properties for both dimenhydrinate and diazepam as compared to the placebo. For the time intervals studied, the maximum effect was obtained at 120 min for both drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7131636

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  4 in total

1.  Cinnarizine/betahistine combination vs. the respective monotherapies in acute peripheral vertigo: a randomized triple-blind placebo-controlled trial.

Authors:  Payman Asadi; Seyyed Mahdi Zia Ziabari; Alireza Majdi; Karim Vatanparast; Seyed Ahmad Naseri Alavi
Journal:  Eur J Clin Pharmacol       Date:  2019-08-16       Impact factor: 2.953

Review 2.  Antihistamines for motion sickness.

Authors:  Nadine Karrim; Ryan Byrne; Nombulelo Magula; Yougan Saman
Journal:  Cochrane Database Syst Rev       Date:  2022-10-17

Review 3.  Pharmacological treatment of vertigo.

Authors:  Timothy C Hain; Mohammed Uddin
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 4.  Neurotology: definitions and evidence-based therapies - Results of the I Brazilian Forum of Neurotology.

Authors:  Márcio Cavalcante Salmito; Francisco Carlos Zuma E Maia; Mário Edvin Gretes; Alessandra Venosa; Fernando Freitas Ganança; Maurício Malavasi Ganança; Raquel Mezzalira; Roseli Saraiva Moreira Bittar; Alexandre Camilotti Gasperin; Anna Paula Batista de Ávila Pires; Bernardo Faria Ramos; César Bertoldo; Cícero Ferreira; Danilo Real; Humberto Afonso Guimarães; Jeanne Oiticica; Joel Lavinsky; Karen Carvalho Lopes; Juliana Antoniolli Duarte; Lígia Oliveira Gonçalves Morganti; Lisandra Megumi Arima Dos Santos; Lúcia Joffily; Luíz Lavinsky; Mônica Alcantara de Oliveira Santos; Patrícia Mauro Mano; Pedro Ivo Machado Pires de Araújo; Pedro Luís Mangabeira Albernaz; Renato Cal; Ricardo Schaffeln Dorigueto; Rita de Cássia Cassou Guimarães; Rogério Castro Borges de Carvalho
Journal:  Braz J Otorhinolaryngol       Date:  2019-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.